BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Impact Events

More
Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
2/15/19 Nektar (NKTR) NKTR-214 for Solid Tumors Subscribers Only Subscribers Only Subscribers Only
2/15/19 Merck (MRK) Keytruda for Renal Cell Cancer (RCC) Subscribers Only Subscribers Only Subscribers Only
2/15/19 Bayer (BAYRY) Vitrakvi for Solid Tumors Subscribers Only Subscribers Only Subscribers Only
2/14/19 Merck (MRK) Keytruda for Prostate Cancer Subscribers Only Subscribers Only Subscribers Only
2/14/19 Bristol-Myers Squibb (BMY) Opdivo for Prostate Cancer Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected
Date Range
Lead
Company
Drug Expected
Catalyst
02/16/19 Subscribers Only Subscribers Only Trial Data - Updated Results
02/16/19 Subscribers Only Subscribers Only Trial Data - Top-Line Results
02/16/19 Subscribers Only Subscribers Only Trial Data - Updated Results
02/16/19 Subscribers Only Subscribers Only Trial Data - Updated Results
Now - 02/18/19 Subscribers Only Subscribers Only Regulatory - Approval Decision (Europe)
Back to the top Back to the top